EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neuroprotection for neonatal hypoxic–ischemic encephalopathy: A review of novel therapies evaluated in clinical studies

Natalie H Chan iD, Cheryl C Hawkins, Benjamin V Rodrigues, Marie-Coralie Cornet, Fernando F Gonzalez, Yvonne W Wu

Developmental Medicine & Child Neurology · 2025

DOI: 10.1111/dmcn.16184 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Developmental Medicine & Child Neurology, 2025. Verfasst von Natalie H Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Hypothermia, Induced, Neuroprotective Agents, Neuroprotection. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic hypothermia is an effective therapy for moderate‐to‐severe hypoxic–ischemic encephalopathy (HIE) in infants born at term or near‐term in high‐resource settings. Yet there remains a substantial proportion of infants who do not benefit or who will have significant disability despite therapeutic hypothermia. Novel investigational therapies that may confer additional neuroprotection by targeting known pathogenic mechanisms of hypoxic–ischemic brain injury are under development. This review focuses on putative neuroprotective agents that have shown promise in animal models of HIE, and that have been translated to clinical studies in neonates with HIE. We include agents that have been studied both with and without concurrent therapeutic hypothermia. Our review therefore addresses not just neonatal HIE in high‐resource countries where therapeutic hypothermia is the standard of care, but also neonatal HIE in low‐ and middle‐income countries where therapeutic hypothermia has been shown to be ineffective, and where the greatest burden of HIE‐related morbidity and mortality exists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Ischemia, BrainHypothermia, InducedNeuroprotective AgentsNeuroprotectionHumansInfant, NewbornAnimals

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • Department of Pediatrics, University of California, San Francisco, California, USA.
  • Department of Neurology, University of California, San Francisco, California, USA.

ORCID-Profile: Natalie H Chan

Zitieren

APA

Chan, N. H., Hawkins, C. C., Rodrigues, B. V., Cornet, M. C., Gonzalez, F. F., & Wu, Y. W. (2025). Neuroprotection for neonatal hypoxic–ischemic encephalopathy: A review of novel therapies evaluated in clinical studies. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.16184

Vancouver

Chan NH, Hawkins CC, Rodrigues BV, Cornet MC, Gonzalez FF, Wu YW. Neuroprotection for neonatal hypoxic–ischemic encephalopathy: A review of novel therapies evaluated in clinical studies. Developmental Medicine & Child Neurology. 2025. doi:10.1111/dmcn.16184

BibTeX
@article{Chan2025,
  author = {Chan, Natalie H and Hawkins, Cheryl C and Rodrigues, Benjamin V and Cornet, Marie-Coralie and Gonzalez, Fernando F and Wu, Yvonne W},
  title = {Neuroprotection for neonatal hypoxic–ischemic encephalopathy: A review of novel therapies evaluated in clinical studies},
  journal = {Developmental Medicine & Child Neurology},
  year = {2025},
  doi = {10.1111/dmcn.16184}
}
Kostenlos starten →